Onclara™ (by Onc.ai)

by Onc.ai  · Based in United States → — AI-powered technology bringing clarity to cancer treatment decisions.
Oncology Pulmonology Radiology

Regulatory Status Disclosed

Overview

Onc.ai is a digital health company dedicated to radically improving oncology decision-making through advanced AI. Their flagship Onclara™ platform leverages a market-leading real-world oncology dataset to train best-in-class predictive and prognostic AI models. This technology aims to provide physicians and pharmaceutical companies with deeper insights for more effective cancer treatment strategies and clinical trial management.

The Onclara™ platform offers two primary products: Onclara™ Evaluate and Onclara™ IO. This product helps optimize trial design and patient selection, potentially accelerating the development of new cancer therapies.

Onclara™ IO focuses on clinical practice, specifically predicting response and outcomes for patients with metastatic lung cancer treated with immunotherapy. By providing prognostic insights, Onclara™ IO can assist physicians in personalizing treatment plans and managing patient expectations more effectively. The platform’s models are continuously validated against comprehensive real-world datasets, ensuring their relevance and accuracy in a clinical setting.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered predictive and prognostic models
  • Leverages real-world oncology datasets
  • Improves Phase IB/Phase II clinical trial decision-making
  • Predicts response and outcomes for metastatic lung cancer with immunotherapy
  • Imaging AI for oncology
  • Serial Imaging Response Score (SIRS)
  • Validated on comprehensive real-world datasets (e.g., Flatiron Health)

Use Cases

  • Optimizing oncology clinical trial design and patient selection
  • Predicting immunotherapy response in metastatic lung cancer
  • Personalizing cancer treatment plans
  • Early assessment of NSCLC immunotherapy outcomes
  • Enhancing clinical decision-making in oncology

What Physicians Need to Know

Evidence Base
The Onclara™ platform leverages a market-leading oncology real-world dataset to train predictive and prognostic AI models.
Clinical Validation Studies
Onclara™ IO was validated on a comprehensive metastatic real-world dataset from Flatiron Health (ASCO 2026). Onc.AI models have ongoing validation through posters and abstracts at ASCO (2025) and GSK validation of Serial CTRS at AACR (2025).
Clinical Workflow Integration
The platform aims to bring clarity to decision-making in oncology clinical trials and clinical practice.
Physician Tip

Onclara™ offers AI-powered insights for predicting response and outcomes in metastatic lung cancer patients treated with immunotherapy. It also provides tools to improve decision-making in Phase IB/Phase II clinical trials.

The platform leverages a real-world dataset from Flatiron Health for validation and model training.

Details

Category Clinical Decision Support & Reference, Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-hosted (Onclara™ Studio, Microsoft Azure Foundry)
Mobile AppOncoCare (by Onco AI) is available on the Apple App Store, but it is unclear if this is directly related to Onc.ai's Onclara™ platform.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Pulmonology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Onclara™ (by Onc.ai)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Onclara™ (by Onc.ai).

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Onclara™ provides AI-powered insights to bring clarity to decision-making in oncology clinical trials and clinical practice.
Onclara™ is for physicians involved in oncology clinical trials and clinical practice, specifically for metastatic lung cancer patients treated with Immunotherapy.
The Onclara™ platform leverages a market-leading oncology real-world dataset to train its predictive and prognostic AI models.
Onclara™ Evaluate improves Phase IB/Phase II clinical trial decision-making, and Onclara™ IO predicts response and outcomes for metastatic lung cancer patients treated with Immunotherapy.
Onclara™ products are limited by U.S. law to investigational use.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-06-19 | First Added: 2026-06-19

Investors who backed Onclara™ (by Onc.ai)

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.